home / stock / taug / taug news


TAUG News and Press, Tauriga Sciences Inc From 12/24/20

Stock Information

Company Name: Tauriga Sciences Inc
Stock Symbol: TAUG
Market: OTC
Website: tauriga.com

Menu

TAUG TAUG Quote TAUG Short TAUG News TAUG Articles TAUG Message Board
Get TAUG Alerts

News, Short Squeeze, Breakout and More Instantly...

TAUG - Tauriga Sciences Inc. Funds the Entirety of the Master Services Agreement that it Recently Entered Into with CSTI

The Company has Now Resumed the Clinical Development of its Proposed Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum™ NEW YORK, NY, Dec. 24, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the ȁ...

TAUG - Tauriga Sciences Inc. to Expand its Existing Product Line of CBD Infused Bath Bombs, Branded Under the Tauri-Gum Name

This Product Line Expansion Will Include 2 Distinct Cannabigerol (“CBG”) Infused Bath Bomb Fragrances NEW YORK, NY, Dec. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”...

TAUG - Tauriga Sciences Inc. Completes Translated Version of its Tauri-Gum Packaging Language: Mandarin Chinese

The Company Plans to Launch its Tauri-Gum™ Product Line throughout Mainland China, During Calendar Year 2021 NEW YORK, NY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company...

TAUG - Tauriga Sciences Inc. Enters into Master Services Agreement with CSTI to Resume the Clinical Development of its Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum

The Company’s Proposed Pharma Grade Version of Tauri-Gum™ is Being Developed Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment (the “Indication”) NEW YORK, NY, Dec. 18, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Taur...

TAUG - Tauriga to resume clinical work for pharmaceutical-grade Tauri-Gum

Tauriga Sciences (TAUG) announces the resumption of clinical development for its proposed “Anti-Nausea” pharmaceutical-grade version of Tauri-Gum™. The company, focused on the Cannabidiol and Cannabigerol Edibles market, filed a provisional U.S. patent in M...

TAUG - Tauriga Sciences Inc. to Resume the Clinical Development of its Proposed "Anti-Nausea" Pharmaceutical Grade Version of Tauri-Gum

Snapshot of U.S. Patent Assignment / PTAS (# 506080043)

TAUG - Tauriga Sciences Inc. Obtains its FEDLINKS Badge as a Verified Federal Government Vendor

NEW YORK, NY, Dec. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement&#...

TAUG - Tauriga Sciences Inc. Surpasses the 10,000 Follower(s) Threshold on its Instagram Page - @taurigum

The “Swipe Up” Feature has been Activated, Enhancing the Company’s E-Commerce Business NEW YORK, NY, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...

TAUG - Tauriga Sciences Inc. Commences Development of Vegan, CBD Infused Pet Treat

NEW YORK, NY - ( NewMediaWire ) - December 11, 2020 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Fla...

TAUG - Tauriga Sciences Inc. to Further Expand & Diversify its Product Offerings with the Launch of CBD Infused Honey

This Product is Comprised of Raw Linden Honey Infused with 500mg CBD / Each Jar Contains 20 Servings (25mg CBD per Serving) NEW YORK, NY, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Com...

Previous 10 Next 10